1[1]Thompsom WJ, Longstreth GF, Drossman DA, et al. Rome Ⅱ:Functional gastrointestinal disorders: diagnosis, pathophysiology,and treatment. 2nd ed. Mc Lean, VA: Degnon Associates, Inc 2000.
2[2]Wingate D, Hongo M, Kellow J, et al. Disorders of gastrointestinal motility: towards a new classification. J Gastroenterol Hepatol 2002;17 Suppl:Sl-14.
3[3]Quartero AO, De Wit NJ, Lodder AC, et al. Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis. Dig Dis Sci 1998;43:2028-2033.
4[4]Mertz H, Fullerton S, Naliboff B, et al. Symptoms and visceral perception and severe functional and organic dyspepsia. Gut 1998;42:814-822.
5[5]Delvaux M. Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome. Gut 2002;51 ( suppl 1 ) :i67-71.
6[6]Bouin M, Plourade V, Boivin M, et al. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity and predictive values of pain sensory thresholds. Gastroenterology 2002;122: 1771-1777.
7[7]Saruc M, Ozden N, Turkel N, et al. Functional dyspepsia: relationship between clinical subgroups and Helicobacter pylori status in Western Turkey. Braz J Med Biol Res 2003;36:747-751.
8[8]Quigley EM. Current concepts of the irritable bowel syndrome.Scand J Gastroenterol Suppl 2003; ( 237 ) :1-8.
9[9]Gwee KA, Collins SM, Marshal JS, et al. Evidence of inflammatory pathogenesis in post-infections irritable bowel syndrome. Gastroenterology 1998; 114:930.
1Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: post survey of patients. BMJ, 1997, 314: 779-781.
2Drossman DA,Thompson WG, Talley NJ, et al. Identification of sub-groups of functional gastrointestinal disorders. Gastroenterol Int, 1990, 3:159-172.
3Jobin C , Gauthier J. Differential effects of cell density on 5-lipoxygenase, 5-lipooxygenase-activating protein and interleukin-1beta expression in human neutrophils. Infla mmation, 1997, 21:235-250.
5Swain MG, Blennerhassett PA, Collins SM. Impaired sympathetic nerve function in the inflamed rat intestine. Gastroenterology,1991,100:675-682.
6Kubota Y, Petras RE, Ottaway CA, et al. Colonic vasoactive intestinal peptide nerves in infla mmatory bowel disease. Gastroenterology, 1992,102:1242-1251.
7Gwee KA, Collins SM, Marshall JS, et al. Evidence of infla mmatory pathogenesis in post- infectious irritable bowel syndrome. Gastroenterology, 1998,114:A930.
8Collins SM. Irritable bowel syndrome could be an infla mmatory disorder. Eur J Gastroenterol Hepatol, 1994,6:478-483.
9Khan I, Collins SM. Interleukin-1β inhibits sodium pump activity in the small intestine of rat. Gastroenterology, 1994,106:A523.
10Ferreira SH, Lorenzetti BB, Bristow AF, et al. Interleukin-1beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature ,1988,334:698-700.
